Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:34646265

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer.

Junhong Shi · Meiyu Bao · Weifeng Wang · Xuan Wu · Yueying Li · Changdong Zhao · Weiwei Liu

Frontiers in immunology · 2021 doi:10.3389/fimmu.2021.722807

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:34646265
kind
science-record
content_hash
sha256:f8677f170b95043e24505b2c19fb703ba412b9e3263e7dc77da202bc2ede6b68
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T17:36:17Z
updated_at
2026-11-01T22:47:42Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer.
doi
10.3389/fimmu.2021.722807
pmid
34646265
authors array · 7 items
[0]
Junhong Shi
[1]
Meiyu Bao
[2]
Weifeng Wang
[3]
Xuan Wu
[4]
Yueying Li
[5]
Changdong Zhao
[6]
Weiwei Liu
journal
Frontiers in immunology
year
2021
abstract
Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 3 (PLOD3) is related to a variety of human diseases. However, its function in Colorectal cancer (CRC) remains uncertain. PLOD3 expression was analyzed using The Cancer Genome Atlas (TCGA) pan-cancer data. DAVID was used for enrichment analysis of PLOD3-related genes. The correlation between PLOD3 expression and immune cell infiltration was evaluated. Four expression profile datasets (GSE17536, GSE39582, GSE74602, and GSE113513) from Gene Expression Omnibus, and two proteomic datasets were used as validation cohorts for assessing the diagnostic and prognostic value of PLOD3 in CRC. What's more, we performed immunohistochemistry (IHC) staining for PLOD3 in 160 paired CRC specimens and corresponding adjacent non-tumor tissues. PLOD3 was highly expressed in many tumors including CRC. PLOD3 was upregulated in advanced stage CRCs, and high PLOD3 expression was associated with poor survival. High PLOD3 expression was associated with low levels of B cells, CD4+ T cells, M1 macrophages, CD8+ T cells, and multiple immunerelated characteristics. In addition, the high PLOD3 expression group had a higher TIDE score and a lower tumor mutation burden and microsatellite instability, indicating that patients with high PLOD3 expression may be resistant to immunotherapy. Additional datasets and IHC analysis were used to validate the diagnostic and prognostic value of PLOD3 at the mRNA and protein levels in CRC. Patients with non-response to immunotherapy showed increased PLOD3 expression in an immunotherapy treated dataset. PLOD3 is a potential biomarker for CRC diagnosis and prognosis prediction. CRCs with high PLOD3 expression may be resistant to immune checkpoint therapy.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34646265
locator
sections[11] "Statistical Analysis" paragraph 2
quote
Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The datasets analyzed during this study are available in the TCGA database (https://portal.gdc.cancer.gov) (TCGA-COAD and TCGA-READ), GEO database (https://www.ncbi.nlm.nih.gov/geo) (GSE17536, GSE39582, GSE74602, and GSE113513).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34646265
locator
sections[20] "Data Availability Statement" paragraph 2
quote
The datasets analyzed during this study are available in the TCGA database (https://portal.gdc.cancer.gov) (TCGA-COAD and TCGA-READ), GEO database (https://www.ncbi.nlm.nih.gov/geo) (GSE17536, GSE39582, GSE74602, and GSE113513).
state
complete
[2] object · 6 fields
id
claim-target-result
statement
PLOD3 was overexpressed in CRC tumor tissue compared with adjacent normal tissue in tissue-microarray immunohistochemistry (p-value = 4.2e-14).
kind
quantitative
target object · 4 fields
value
4
unit
p-value
tolerance
null
source
Grossly, PLOD3 was overexpressed in tumor parts comparing to normal specimens ( Figure 6F , p-value = 4.2e-14).
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34646265
locator
sections[18] "Validation of the Diagnostic and Prognostic Value of PLOD3" paragraph 2
quote
Grossly, PLOD3 was overexpressed in tumor parts comparing to normal specimens ( Figure 6F , p-value = 4.2e-14).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
PLOD3 was overexpressed in CRC tumor tissue compared with adjacent normal tissue in tissue-microarray immunohistochemistry (p-value = 4.2e-14).
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:34646265
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:group_comparison_wilcoxon
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 2 items
[0]
step:run_analysis blocked on method:group_comparison_wilcoxon
[1]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 1 item
[0] object · 15 fields
id
source:pmid:34646265
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fimmu.2021.722807
sha256
sha256:2fd79a1e744006a8fced7987d812056916c9d36290c165dd72e37b1f351e81b1
bytes
40503
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fimmu.2021.722807
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8503557
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 4 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
wilcoxon
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
verbatim
quote
Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[3] object · 10 fields
id
method-4
family
diagnostic_evaluation
specific
roc
label
Diagnostic test evaluation
dsl_operations array · 6 items
[0]
confusion_counts
[1]
roc_curve
[2]
sensitivity_specificity
[3]
solve_confusion_matrix
[4]
classification_metrics
[5]
published_precision_envelope
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
reference_standard_and_test
evidence object · 3 fields
score
0.8
band
high
quote
ROC curve
targets array · 1 item
[0] object · 8 fields
id
target-published-estimate
claim_id
claim-target-result
operation
classification_metrics
unit
p-value
tolerance
null
state
complete
note
The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold.
gaps array · 1 item
[0]
method.group_comparison_wilcoxon
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
[0]
The datasets analyzed during this study are available in the TCGA database (https://portal.gdc.cancer.gov) (TCGA-COAD and TCGA-READ), GEO database (https://www.ncbi.nlm.nih.gov/geo) (GSE17536, GSE39582, GSE74602, and GSE113513).
basis
The paper names no accession to its source data, so the data has to come from the authors.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 1 item
[0]
source:pmid:34646265
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
group_comparison_wilcoxon
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:04:01Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
12724
completion_tokens
2589
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:34646265
type
paper
label
pmid:34646265
[1] object · 3 fields
id
source:pmid:34646265
type
manuscript
label
PMID 34646265 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:34646265
type
paper
label
pmid:34646265
[1] object · 3 fields
id
source:pmid:34646265
type
manuscript
label
PMID 34646265 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-34646265
type
extraction
used array · 1 item
[0]
source:pmid:34646265
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:34646265
parent_hash
sha256:d5f12b82745ad33f64b564bbd28e11891eead39bcf93ffad799cab7bb1e39924
fork_of
null
gaps array · 7 items
[0]
execution.not_run
[1]
method.group_comparison_wilcoxon
[2]
review.human_critique
[3]
review.independent_reader
[4]
review.machine_critique
[5]
step:obtain_source_data blocked on data:accession_absent
[6]
step:run_analysis blocked on method:group_comparison_wilcoxon
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
e of PLOD3 in CRC. What's more, we performed immunohistochemistry (IHC) staining for PLOD3 in 160 paired CRC s
[1]
t's more, we performed immunohistochemistry (IHC) staining for PLOD3 in 160 paired CRC specim
[2]
nt to immunotherapy. Additional datasets and IHC analysis were used to validate the diagnosti
order_basis
paper_text_order:740
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
hical approval code is 2020-KN155-01. Tissue microarray was constructed by 1.5-mm cores. Statistical
order_basis
paper_text_order:2313
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package.
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34646265", "kind": "science-record", "revision": 5, "content_hash": "sha256:f8677f170b95043e24505b2c19fb703ba412b9e3263e7dc77da202bc2ede6b68", "created_at": "2026-11-01T17:36:17Z", "updated_at": "2026-11-01T22:47:42Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer.", "doi": "10.3389/fimmu.2021.722807", "pmid": "34646265", "authors": ["Junhong Shi", "Meiyu Bao", "Weifeng Wang", "Xuan Wu", "Yueying Li", "Changdong Zhao", "Weiwei Liu"], "journal": "Frontiers in immunology", "year": 2021, "abstract": "Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 3 (PLOD3) is related to a variety of human diseases. However, its function in Colorectal cancer (CRC) remains uncertain. PLOD3 expression was analyzed using The Cancer Genome Atlas (TCGA) pan-cancer data. DAVID was used for enrichment analysis of PLOD3-related genes. The correlation between PLOD3 expression and immune cell infiltration was evaluated. Four expression profile datasets (GSE17536, GSE39582, GSE74602, and GSE113513) from Gene Expression Omnibus, and two proteomic datasets were used as validation cohorts for assessing the diagnostic and prognostic value of PLOD3 in CRC. What's more, we performed immunohistochemistry (IHC) staining for PLOD3 in 160 paired CRC specimens and corresponding adjacent non-tumor tissues. PLOD3 was highly expressed in many tumors including CRC. PLOD3 was upregulated in advanced stage CRCs, and high PLOD3 expression was associated with poor survival. High PLOD3 expression was associated with low levels of B cells, CD4+ T cells, M1 macrophages, CD8+ T cells, and multiple immunerelated characteristics. In addition, the high PLOD3 expression group had a higher TIDE score and a lower tumor mutation burden and microsatellite instability, indicating that patients with high PLOD3 expression may be resistant to immunotherapy. Additional datasets and IHC analysis were used to validate the diagnostic and prognostic value of PLOD3 at the mRNA and protein levels in CRC. Patients with non-response to immunotherapy showed increased PLOD3 expression in an immunotherapy treated dataset. PLOD3 is a potential biomarker for CRC diagnosis and prognosis prediction. CRCs with high PLOD3 expression may be resistant to immune checkpoint therapy.", "claims": [{"id": "claim-method", "statement": "Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34646265", "locator": "sections[11] \"Statistical Analysis\" paragraph 2", "quote": "Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The datasets analyzed during this study are available in the TCGA database (https://portal.gdc.cancer.gov) (TCGA-COAD and TCGA-READ), GEO database (https://www.ncbi.nlm.nih.gov/geo) (GSE17536, GSE39582, GSE74602, and GSE113513).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34646265", "locator": "sections[20] \"Data Availability Statement\" paragraph 2", "quote": "The datasets analyzed during this study are available in the TCGA database (https://portal.gdc.cancer.gov) (TCGA-COAD and TCGA-READ), GEO database (https://www.ncbi.nlm.nih.gov/geo) (GSE17536, GSE39582, GSE74602, and GSE113513)."}], "state": "complete"}, {"id": "claim-target-result", "statement": "PLOD3 was overexpressed in CRC tumor tissue compared with adjacent normal tissue in tissue-microarray immunohistochemistry (p-value = 4.2e-14).", "kind": "quantitative", "target": {"value": 4.0, "unit": "p-value", "tolerance": null, "source": "Grossly, PLOD3 was overexpressed in tumor parts comparing to normal specimens ( Figure 6F , p-value = 4.2e-14)."}, "evidence": [{"asset": "source:pmid:34646265", "locator": "sections[18] \"Validation of the Diagnostic and Prognostic Value of PLOD3\" paragraph 2", "quote": "Grossly, PLOD3 was overexpressed in tumor parts comparing to normal specimens ( Figure 6F , p-value = 4.2e-14)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "PLOD3 was overexpressed in CRC tumor tissue compared with adjacent normal tissue in tissue-microarray immunohistochemistry (p-value = 4.2e-14).", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34646265"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:group_comparison_wilcoxon", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:group_comparison_wilcoxon", "step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34646265", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fimmu.2021.722807", "sha256": "sha256:2fd79a1e744006a8fced7987d812056916c9d36290c165dd72e37b1f351e81b1", "bytes": 40503, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fimmu.2021.722807", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8503557", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-4", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.8, "band": "high", "quote": "ROC curve"}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "classification_metrics", "expected_value": 4.0, "unit": "p-value", "tolerance": null, "state": "complete", "note": "The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold."}], "gaps": ["method.group_comparison_wilcoxon"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["The datasets analyzed during this study are available in the TCGA database (https://portal.gdc.cancer.gov) (TCGA-COAD and TCGA-READ), GEO database (https://www.ncbi.nlm.nih.gov/geo) (GSE17536, GSE39582, GSE74602, and GSE113513)."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:34646265"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "group_comparison_wilcoxon", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:04:01Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 12724, "completion_tokens": 2589, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34646265", "type": "paper", "label": "pmid:34646265"}, {"id": "source:pmid:34646265", "type": "manuscript", "label": "PMID 34646265 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34646265", "type": "paper", "label": "pmid:34646265"}, {"id": "source:pmid:34646265", "type": "manuscript", "label": "PMID 34646265 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34646265", "type": "extraction", "used": ["source:pmid:34646265"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34646265", "parent_hash": "sha256:d5f12b82745ad33f64b564bbd28e11891eead39bcf93ffad799cab7bb1e39924", "fork_of": null, "generation": 4}, "gaps": ["execution.not_run", "method.group_comparison_wilcoxon", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent", "step:run_analysis blocked on method:group_comparison_wilcoxon"], "assays": [{"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["e of PLOD3 in CRC. What's more, we performed immunohistochemistry (IHC) staining for PLOD3 in 160 paired CRC s", "t's more, we performed immunohistochemistry (IHC) staining for PLOD3 in 160 paired CRC specim", "nt to immunotherapy. Additional datasets and IHC analysis were used to validate the diagnosti"], "order_basis": "paper_text_order:740", "id": "assay:1"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["hical approval code is 2020-KN155-01. Tissue microarray was constructed by 1.5-mm cores. Statistical"], "order_basis": "paper_text_order:2313", "id": "assay:2"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Differences in variables between groups were tested using the Wilcoxon test or chi-squared test, as appropriate. Kaplan-Meier curves were drawn to estimate the overall survival distribution. The log-rank test was used to analyze the statistical difference in survival curves between two groups. Kruskal-Wallis tests were used for comparing PLOD3’s expression difference among more than two comparison groups and Wilcoxon test was used for comparison between two groups. The ROC curve was plotted via “pROC” package."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}